Well, if any of the new deals are China, I’d say
Post# of 36537
The China partners alone are bigger than Pfizer.
If the China deal is signed, Generex / NGIO sand shareholders score big, because while waiting on the vaccine, they still have Excellegen and AE37 in the deal too.
We really need to hear this deal getting signed then it should be off to the races. NGIO then getting listed is icing on the cake. Arizona and the MSO and everything else is added bonus too.